• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Differential expression of mGluR5 metabotropic glutamate receptor mRNA by rat striatal neurons.

作者信息

Testa C M, Standaert D G, Landwehrmeyer G B, Penney J B, Young A B

机构信息

Neurology Service, Massachusetts General Hospital, Boston 02114, USA.

出版信息

J Comp Neurol. 1995 Apr 3;354(2):241-52. doi: 10.1002/cne.903540207.

DOI:10.1002/cne.903540207
PMID:7782501
Abstract

Metabotropic glutamate receptors (mGluRs) mediate the effects of glutamate neurotransmission on intracellular second messenger systems. Among the seven distinct mGluR receptor isoforms currently identified, the mGluR5 isoform is expressed particularly prominently in the striatum, where it may contribute to neuronal plasticity, motor behaviors, and excitotoxic injury. mGluR5 mRNA expression in striatal enkephalinergic, somatostatinergic, and cholinergic neurons was examined using double label in situ hybridization techniques. mGluR5 expression is abundant in a large number of medium-sized striatal cells but is absent in a significant minority of neurons. Double label in situ hybridization with 35S-dATP- and digoxygenin-dUTP-tailed oligonucleotide probes demonstrated that mGluR5 message is highly expressed by enkephalinergic striatal neurons but is not detectable in cholinergic or somatostatin interneurons. In addition, some nonenkephalin, presumably substance P, neurons were also strongly labeled for mGluR5. The differential expression of mGluR5 in striatal projection neurons vs. interneurons may contribute to the selective vulnerability of these neurons to disease processes.

摘要

相似文献

1
Differential expression of mGluR5 metabotropic glutamate receptor mRNA by rat striatal neurons.
J Comp Neurol. 1995 Apr 3;354(2):241-52. doi: 10.1002/cne.903540207.
2
Comparative analysis of the subcellular and subsynaptic localization of mGluR1a and mGluR5 metabotropic glutamate receptors in the shell and core of the nucleus accumbens in rat and monkey.大鼠和猴伏隔核壳部与核心中促代谢型谷氨酸受体1a(mGluR1a)和促代谢型谷氨酸受体5(mGluR5)的亚细胞及突触下定位的比较分析
J Comp Neurol. 2007 Feb 1;500(4):788-806. doi: 10.1002/cne.21214.
3
Expression of metabotropic glutamate receptor 5 is increased in astrocytes after kainate-induced epileptic seizures.在海藻酸诱导的癫痫发作后,星形胶质细胞中代谢型谷氨酸受体5的表达增加。
Glia. 2000 Jun;30(4):352-61.
4
Phenotypical characterization of the neurons expressing the D1 and D2 dopamine receptors in the monkey striatum.恒河猴纹状体中表达D1和D2多巴胺受体的神经元的表型特征
J Comp Neurol. 2000 Feb 28;418(1):22-32.
5
Multiplicity of glutamate receptor subunits in single striatal neurons: an RNA amplification study.单纹状体神经元中谷氨酸受体亚基的多样性:一项RNA扩增研究。
Mol Pharmacol. 1996 May;49(5):852-9.
6
Cellular localization of mGluR3 and mGluR5 mRNAs in normal and injured rat brain.正常和损伤大鼠脑中代谢型谷氨酸受体3(mGluR3)和代谢型谷氨酸受体5(mGluR5)信使核糖核酸的细胞定位
Brain Res. 2007 May 29;1149:1-13. doi: 10.1016/j.brainres.2007.02.041. Epub 2007 Feb 27.
7
Global ischemia downregulates the function of metabotropic glutamate receptor subtype 5 in hippocampal CA1 pyramidal neurons.全脑缺血下调海马CA1区锥体神经元代谢型谷氨酸受体5的功能。
Mol Cell Neurosci. 2005 Jul;29(3):484-92. doi: 10.1016/j.mcn.2005.04.001.
8
Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat.大鼠基底神经节中代谢型谷氨酸受体mRNA的表达
J Neurosci. 1994 May;14(5 Pt 2):3005-18. doi: 10.1523/JNEUROSCI.14-05-03005.1994.
9
Dysfunction of the cortico-basal ganglia-cortical loop in a rat model of early parkinsonism is reversed by metabotropic glutamate receptor 5 antagonism.在早期帕金森病大鼠模型中,代谢型谷氨酸受体5拮抗作用可逆转皮质-基底神经节-皮质环路的功能障碍。
Eur J Neurosci. 2005 Dec;22(11):2765-74. doi: 10.1111/j.1460-9568.2005.04498.x.
10
Pharmacological regulation of striatal gene expression by metabotropic glutamate receptors.代谢型谷氨酸受体对纹状体基因表达的药理学调控
Zhongguo Yao Li Xue Bao. 1999 Jul;20(7):577-84.

引用本文的文献

1
Ca waves in astrocytes: computational modeling and experimental data.星形胶质细胞中的钙波:计算建模与实验数据
Front Cell Neurosci. 2025 Mar 28;19:1536096. doi: 10.3389/fncel.2025.1536096. eCollection 2025.
2
Presynaptic Gq-coupled receptors drive biphasic dopamine transporter trafficking that modulates dopamine clearance and motor function.突触前 Gq 偶联受体驱动多巴胺转运体的双相转运,从而调节多巴胺的清除和运动功能。
J Biol Chem. 2023 Feb;299(2):102900. doi: 10.1016/j.jbc.2023.102900. Epub 2023 Jan 12.
3
Targeting the Type 5 Metabotropic Glutamate Receptor: A Potential Therapeutic Strategy for Neurodegenerative Diseases?
靶向代谢型谷氨酸受体5:神经退行性疾病的潜在治疗策略?
Front Pharmacol. 2022 May 11;13:893422. doi: 10.3389/fphar.2022.893422. eCollection 2022.
4
Modeling dopamine dysfunction in autism spectrum disorder: From invertebrates to vertebrates.自闭症谱系障碍中多巴胺功能障碍的建模:从无脊椎动物到脊椎动物。
Neurosci Biobehav Rev. 2022 Feb;133:104494. doi: 10.1016/j.neubiorev.2021.12.017. Epub 2021 Dec 11.
5
Regulation of Glutamatergic Activity via Bidirectional Activation of Two Select Receptors as a Novel Approach in Antipsychotic Drug Discovery.通过双向激活两种选择性受体调节谷氨酸能活性,作为一种新型抗精神病药物发现方法。
Int J Mol Sci. 2020 Nov 20;21(22):8811. doi: 10.3390/ijms21228811.
6
mGluR5 Allosteric Modulation Promotes Neurorecovery in a 6-OHDA-Toxicant Model of Parkinson's Disease.代谢型谷氨酸受体 5 的变构调节促进了 6-羟基多巴胺中毒帕金森病模型中的神经恢复。
Mol Neurobiol. 2020 Mar;57(3):1418-1431. doi: 10.1007/s12035-019-01818-z. Epub 2019 Nov 21.
7
The Role of Extracellular Signal-Regulated Kinases (ERK) in the Regulation of mGlu5 Receptors in Neurons.细胞外信号调节激酶(ERK)在神经元中调节 mGlu5 受体中的作用。
J Mol Neurosci. 2018 Dec;66(4):629-638. doi: 10.1007/s12031-018-1193-0. Epub 2018 Nov 15.
8
Genetic Knockdown of mGluR5 in Striatal D1R-Containing Neurons Attenuates L-DOPA-Induced Dyskinesia in Aphakia Mice.纹状体 D1R 神经元中 mGluR5 的基因敲低可减轻无眼畸形小鼠的 L-DOPA 诱导的运动障碍。
Mol Neurobiol. 2019 Jun;56(6):4037-4050. doi: 10.1007/s12035-018-1356-6. Epub 2018 Sep 27.
9
Cause or compensation?-Altered neuronal Ca handling in Huntington's disease.病因还是补偿机制?——亨廷顿病中神经元钙处理的改变。
CNS Neurosci Ther. 2018 Apr;24(4):301-310. doi: 10.1111/cns.12817. Epub 2018 Feb 9.
10
Glutamatergic mechanisms in L-DOPA-induced dyskinesia and therapeutic implications.L-DOPA 诱导的运动障碍中的谷氨酸能机制及治疗意义。
J Neural Transm (Vienna). 2018 Aug;125(8):1225-1236. doi: 10.1007/s00702-018-1846-8. Epub 2018 Jan 31.